Shrink Sleeve Labels Market 2016 market Share, Regional Analysis and Chronic obstructive pulmonary disease (COPD) | Page 2

Intended Audience          COPD treatment centers Contract Research Organizations (CROs) Research and Development (R&D) Companies Government Research Laboratories Independent Research Laboratories Government and Independent Regulatory Authorities Market Research and Consulting Service Providers Medical Research Laboratories Academic Medical Institutes and Universities Key Players for COPD Market: Some of the key players in this market are:  Abbott (U.S),  AstraZeneca (U.K),  GSK (U.K), F.  Hoffmann-La Roche Ltd (Switzerland),  Novartis AG (Switzerland),  Merck (U.S),  Pfizer Inc (U.S),  Dr. Reddy’s Laboratories Ltd (India). “Ask for your specific company profile and country level customization on reports” Segments: Global COPD market has been segmented    On the basis of type which comprises of chronic bronchitis, emphysema. On the basis of medicines include bronchodilators, inhaled steroids, combination inhalers, oral steroids, phosphodiesterase-4 inhibitors, theophylline and antibiotics. Furthermore On the basis of treatment oxygen therapy, lung transplant, bullectomy and other Regional Analysis of COPD Market: Globally North America is the largest market for COPD. The North American market for COPD is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is due to increasing healthcare awareness in the region. Europe is the secondlargest market for COPD which is expected to grow at a CAGR of XX%. Furthermore Asia pacific market is expected to be the growing market for COPD market. Tel: +1-646-845-9349 [email protected]